Activation of cellular kinases and transcription factors mediates the early phase of the cellular response to chemically or biologically induced stress. In the present study we investigated the oxidant/antioxidant balance in Huh-7 cells expressing the HCV (hepatitis C virus) subgenomic replicon, and observed a 5-fold increase in oxidative stress during HCV replication. We used MnSOD (manganese-superoxide dismutase) as an indicator of the cellular antioxidant response, and found that its activity, protein levels and promoter activity were significantly increased, whereas Cu/ZnSOD was not affected. The oxidative stress-induced protein kinases p38 MAPK (mitogen-activated protein kinase) and JNK (c-Jun N-terminal kinase) were activated in the HCV repliconcontaining cells and in Huh-7 cells transduced with Ad-NS5A [a recombinant adenovirus encoding NS5A (non-structural protein 5A)], coupled with a 4-5-fold increase in AP-1 (activator protein-1) DNA binding. Ava.1 cells, which encode a replicationdefective HCV replicon, showed no significant changes in MnSOD, p38 MAPK or JNK activity. The AP-1 inhibitors dithiothreitol and N-acetylcysteine, as well as a dominant negative AP-1 mutant, significantly reduced AP-1 activation, demonstrating that this activation is oxidative stress-related. Exogenous NS5A had no effect on AP-1 activation in vitro, suggesting that NS5A acts at the upstream targets of AP-1 involving p38 MAPK and JNK signalling cascades. AP-1-dependent gene expression was increased in HCV subgenomic replicon-expressing Huh-7 cells. MnSOD activation was blocked by inhibitors of JNK (JNKI1) and p38 MAPK (SB203580), but not by an ERK (extracellular-signal-regulated kinase) inhibitor (U0126), in HCV-replicating and Ad-NS5A-transduced cells. Our results demonstrate that cellular responses to oxidative stress in HCV subgenomic replicon-expressing and Ad-NS5A-transduced cells are regulated by two distinct signalling pathways involving p38 MAPK and JNK via AP-1 that is linked to increased oxidative stress and therefore to an increased antioxidant MnSOD response.
INTRODUCTION
HCV (hepatitis C virus) infection exhibits a prolonged, insidious course, with progressive liver injury leading to fibrosis and eventually hepatocellular carcinoma [1] . Many complex processes play critical roles in the development of liver damage, including apoptosis, necrosis, inflammation, immune response, fibrosis, ischaemia, altered gene expression and regeneration. Although the mechanisms of cell injury and progression are unclear, emerging evidence thus far presented includes enhanced production of free radicals and disease activity in chronic hepatitis C [2] [3] [4] . Oxidative stress is a condition linked to the activation of two well characterized transcription factors, NFκB (nuclear factor κB) and AP-1 (activator protein-1) [5, 6] . Reports of increases in the levels of malondialdehyde and 4-hydroxynonenal protein adducts during chronic active hepatitis C disease support an in vivo role Abbreviations used: Ad-GFP, recombinant adenovirus encoding GFP; Ad-NS5A, recombinant adenovirus encoding NS5A; AP-1, activator protein-1; CMV, cytomegalovirus; DCF, 2 ,7 -dichlorofluorescein; DCFH-DA, 2 ,7 -dichlorofluorescein diacetate; DMEM, Dulbecco's modified Eagle's medium; DTT, dithiothreitol; EMSA, electrophoretic mobility shift assay; ERK, extracellular-signal-regulated kinase; GFP, green fluorescent protein; GST, glutathione S-transferase; HCV, hepatitis C virus; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; NAC, N-acetylcysteine; NFκB, nuclear factor κB; NS5A, non-structural protein 5A; PKR, double-stranded-RNA-dependent protein kinase; SOD, superoxide dismutase; SRCAP, SNF2-related CBP activator protein [where CBP is CREB (cAMP response element binding protein) binding protein]; STAT5b, signal transduction and activators of transcription 5b; SV40, simian virus 40; TBP, TATA box binding protein; TNF, tumour necrosis factor; TRE, PMA ('TPA')-responsive element. 1 To whom correspondence should be addressed (e-mail ishtiaq.qadri@uchsc.edu).
for reactive oxygen species as mediators of liver damage [2, 7, 8] .
The onset of liver damage will depend on the duration of the toxic insult. As a consequence, it is important to understand the oxidative/antioxidative balance in HCV-infected cells. HCV is a positive-stranded RNA virus distantly related to the flaviviruses and pestiviruses, and has been classified into the genus hepacivirus of the virus family flaviviridae [9, 10] . Immediately following the 5 non-translated region, the order of genes is as follows; 5 -C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-3 [9] [10] [11] (where NS denotes non-structural protein). The 5 nontranslated region consists of ≈ 340 nt, and controls the synthesis of the HCV polyprotein through an IRES (internal ribosome entry site) that is highly conserved [12] .
Research on HCV replication and pathogenesis, as well as the development of therapeutic strategies, has been severely hampered by the lack of reproducible in vitro methods and of an animal model of HCV infection. The majority of attempts to grow HCV in culture have been unsuccessful or have yielded a low virus titre. Recently, an in vitro cell culture-based system using HCV subgenomic replicons was developed [13, 14] . HCV RNA replicon replication occurs in the human hepatic cell line Huh-7, after transfection of a genotype 1b subgenomic RNA replicon expressing a selectable marker. The HCV subgenomic replicon was able to synthesize minus-strand HCV RNA in a cell line referred to as Huh. 8 . A mutant Ava.1 cell line (with a deletion of 47 amino acids of NS5A) was also generated that does not support HCV subgenomic replication. To date, these cell lines carrying HCV subgenomic replicons are the most important tools available for understanding HCV replication and pathogenesis associated with the expression of the NS2-NS5B proteins of HCV in a cell-culture system. HCV NS5A is known to possess potent transcriptional transactivator properties [15] , and displays a multitude of activities related to enhancement of viral pathogenesis by binding to a repertoire of cellular proteins, including cellular PKR (doublestranded-RNA-dependent protein kinase), phosphoinositide 3-kinase, SRCAP [SNF2-related CBP activator protein, where CBP is CREB (cAMP response element binding protein) binding protein], Grb2 and TBP (TATA box binding protein) [16] [17] [18] [19] [20] [21] [22] [23] . We and others have reported functional associations of NS5A with p53 [22, 23] . p53 participates in transcription, cell cycle checkpoints, DNA repair and apoptotic pathways [24] , and alters the cellular redox state [25] . The p53-dependent induction of p21 cip/WAF1 protects cells against oxygen-induced toxicity [26] .
p38 MAPK (mitogen-activated protein kinase), JNK (c-Jun Nterminal kinase) and ERK (extracellular-signal-regulated kinase) are stress-inducible kinases that are activated in response to various extracellular and intracellular stimuli, such as UV light, reactive oxygen species, osmotic shock, chemicals and biological agents, including viruses [27] [28] [29] [30] [31] [32] . These stress-activated kinases are involved in the regulation of p53 [33, 34] . The extent to which activated p38 MAPK, JNK and ERK1/2 influence the functions of p53, including DNA and protein interactions, in the context of oxidative stress and HCV remains to be investigated. To overcome the oxidative burden, the expression of key antioxidant enzymes such as SODs (superoxide dismutases), which are the first enzymes involved in the detoxification of oxygen free radicals, is upregulated. The human MnSOD gene is highly inducible by various physical, chemical and biological agents that trigger oxidative stress [35] [36] [37] [38] [39] . However, it is hypothesized that this activation cannot be sustained throughout the course of the stress, as at some stage the oxidant burden is likely to overwhelm the cells, thus leading to a failure in antioxidant responses. This is evident in a wide variety of tumour cells, where diminished MnSOD activity and mRNA levels occur [35] .
In the present study, we investigated cellular oxidant and antioxidant responses during HCV replication. A 5-fold induction of oxidative stress, coupled with activation of stress-inducible p38 MAPK and JNK and transcription factor AP-1, was observed. p38 MAPK and AP-1 are known to activate the key antioxidant gene MnSOD as a response to the burden of oxidative stress. Consistent with this hypothesis, MnSOD enzyme activity, protein expression and promoter activity were induced in cells undergoing HCV replication. HCV NS5A seems to be responsible for these cellular perturbations, as Ad-NS5A (a recombinant adenovirus encoding NS5A) was able to activate p38 MAPK, JNK and AP-1. The expression of c-fos in HCV-replicating and Ad-NS5A-transduced cells was not affected, but c-jun expression was ≈ 3-fold higher. Inhibitors of JNK and p38 MAPK significantly reduced the activation of MnSOD, while an ERK1/2 inhibitor had no effect, in HCV-replicating and Ad-NS5A-transduced cells. Thus cells expressing an HCV subgenomic replicon respond to stress by activating MnSOD via two distinct signalling pathways involving p38 MAPK, JNK and the transcription factor AP-1.
EXPERIMENTAL Cell lines and culture conditions
Huh.8 cell lines contain the HCV subgenomic replicon expressing NS components (NS2, NS3, NS4A, NS4B, NS5A and NS5B) [4] . The HCV replication-defective cell line Ava.1 (with a deletion of 47 amino acids within the NS5A region) was also employed. Huh-7 cells were cultured in DMEM (Dulbecco's modified Eagle's medium) containing high glucose supplemented with 2 mM Lglutamine, 1 mM sodium pyruvate and 10 % (v/v) fetal bovine serum. Huh.8 and Ava.1 cells were maintained in complete DMEM supplemented with 10 % (v/v) heat-inactivated fetal bovine serum, non-essential amino acids and 1 mg/ml G418. All cells were maintained at 37
• C in a humidified environment containing 5 % CO 2 . 
Antibodies

Monoclonal
Oligonucleotides
The AP-1 consensus probe 5 -CGCTTGATGAGTCAGCCG-GAA-3 (where bold denotes the consensus AP-1 binding site) was used in EMSAs (electrophoretic mobility shift assays). Oligonucleotide 5 -TGGGAACTAGTCCTGACTCAGTTAACTGTG-3 , encompassing the AP-1 binding site of the human MnSOD promoter region (− 840 to − 810) [35, 39] , was used as a competitive DNA in the experiment shown in Figure 7 (A).
Plasmids
pAdTrack/CMV (where CMV is cytomegalovirus) and pAdEasy are described in [40] . The HindIII/XbaI fragment from pNeoCMV/NS5A was excised and cloned into pAdTrack/CMV to obtain pAdTrack/CMV-NS5A. pAdTrack/CMV-NS5A was recombined into pAdEasy-1 to obtain AdEasy-1-NS5A, which was cleaved with PacI prior to transfection into HTK293 cells. The full-length 3400 bp MnSOD promoter-reporter construct MnSOD FL -LUC and the minimal 210 bp MnSOD promoter-reporter construct MnSOD 210 -LUC have been described previously [41] . The construction of pAP-LUC has been described [6, 43] , and this plasmid was kindly provided by D. Brenner (Departments of Medicine and Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC, U.S.A.).
Production of Ad-NS5A
The method of He et al. [40] was employed to construct the recombinant adenovirus for expression of HCV NS5A. To generate Ad-NS5A, pAdTrack/CMV-NS5A was cleaved with PmeI for recombination in Escherichia coli strain BJ334 carrying the pAdEasy-1 vector. Viruses were constructed by transfection of HTK293 cells with the recombinant pAdEasy-1-NS5A plasmid, digested with PacI. The recombinants were selected for kanamycin resistance, and were confirmed first by restriction endonuclease digestion and then by DNA sequencing. Recombinant adenovirus Ad5TAM, expressing TAM-67, a dominant negative cJun (AP-1), was a gift from Dr D. Brenner [43] . To generate adenovirus expressing GFP (green fluorescent protein), pAdTrack/ CMV containing the CMV-GFP cassette was introduced into pAdEasy-1 by homologous recombination in E. coli strain BJ334. High-titre stocks were dialysed in a buffer containing 10 mM Tris/HCl (pH 8.8), 15 mM NaCl, 10 mM MgCl 2 and 10 % (v/v) glycerol, and stored at − 80
• C. The titre of each virus stock was determined by plaque assay using HTK293 cells. Titres were consistently ≈ 1 × 10 11 plaque-forming units/ml.
Measurement of activation of p38 MAPK, JNK and ERK
Cells were washed three times in ice-cold PBS. Cell lysates were obtained by addition of 0.5 ml of lysis buffer [50 mM β-glycerophosphate, pH 7.2, 0.5 % Triton X-100, 0.1 mM sodium vanadate, 2 mM MgCl 2 , 1 mM EGTA, 1 mM DTT (dithiothreitol), 2 µg/ml leupeptin and 4 µg/ml aprotinin] and scraping. The lysates were centrifuged at 4
• C for 10 min at 21 000 g to remove nuclei and cell debris. The supernatants were saved and used for Western blot analysis. Band detection and analysis was performed using a Kodak Image Station CF440. Protein concentrations were determined by the bicinchoninic acid method (Pierce, Rockford, IL, U.S.A.).
Western blotting
SDS/PAGE and immunoblotting were carried out using Minigels. Proteins were transferred by the procedures of Towbin et al. [43a] and processed using enhanced chemiluminescence for detection (Amersham) with specific antibodies using 1 % (w/v) non-fat dried milk in Tris-buffered saline. All washes were in 0.5 % Tween/Tris-buffered saline for 5 min. Analyses of autoradiograms were performed using a PhosphoImager.
Preparation of nuclear proteins
Nuclear proteins were prepared from livers using sucrose gradients. Minced liver tissue was homogenized and filtered through several layers of gauze and adjusted to 0.3 % (v/v) Triton X-100. Sucrose gradients were prepared and the sample was centrifuged at 77 000 g for 50 min at 4
• C. The nuclear pellets were resuspended in buffer and ammonium sulphate was added slowly to a final concentration of 0.4 M. The mixture was centrifuged at 62 000 g for 60 min. The supernatant was saved and 0.33 g of ammonium sulphate per ml of supernatant was added. The mixture was again centrifuged at 62 000 g for 60 min, protein pellets were resuspended and dialysed aliquots were snap-frozen at − 70
• C.
Gel EMSA
The oligonucleotides were radiolabelled with [γ -32 P]dATP using T4 polynucleotide kinase. Binding reaction mixtures contained 20 mM Hepes (pH 7.9), 4 % Ficoll type 400, 50 mM KCl, 0.5 mM EDTA, 100 ng of poly(dI-dC), 50 ng of pSK + DNA (Stratagene) and 20 000 c.p.m. of DNA probe. Reaction mixtures were incubated at 25
• C for 30 min with DNA, nuclear extract and bacterially purified proteins. Appropriate antibodies were either purchased commercially or obtained from individual investigators. The complexes were separated by electrophoresis in a 4.5 % (w/v) native polyacrylamide gel at 120 V at 4
• C in 0.5 × TBE buffer (1 × TBE = 45 mM Tris/borate and 1 mM EDTA).
DNA transfections
Cultures were set up 24 h prior to transfections in 35 mm-diam. 6-well plates at 10 6 cells/well in DMEM containing appropriate supplements. Transfections were carried out using Fugene 6 (Roche Diagonistics), at a 1:1 DNA/lipid ratio. At 48 h posttransfection, cells were harvested and assayed for luciferase activity using a dual luciferase reporter assay system (Promega). Luciferase activity was read in a Packard plate reader luminometer.
SOD activity assays
Briefly, cell extracts were incubated with 1 mM diethyldithiocarbamate in 50 mM potassium phosphate (pH 7.8) at 37
• C for 1 h. Cellular extracts were assayed by the cytochrome method originally described by McCord and Fridovich [42] . For the activity gels, a discontinuous buffer system was used. For the separating gel, a native 8 % (w/v) polyacrylamide gel was prepared in a 150 mM Tris/HCl, pH 8.8, buffer. For the stacking gel, a 6 % acrylamide (29:1 monoacrylamide/bisacrylamide) gel in 126 mM Tris/HCl, pH 6.8, was prepared. The upper and lower tank buffers consisted of 37.6 mM Trizma base/40 mM glycine (pH adjusted to 8.89 with HCl) and 63 mM Tris/HCl (pH 7.4) respectively. The gels were pre-electrophoresed at 50 V for 30 min. Total proteins (50 µg) prepared in a loading buffer containing 70 mM Tris/HCl, pH 6.8, 6 % glycerol and 0.24 % Bromphenol Blue were then resolved for 30 min at 50 V, followed by electrophoresis at 100 V for 1.5 h. After electrophoresis, the gels were carefully rinsed and SOD activity was detected by inhibition of NitroBlue Tetrazolium reduction. SOD activity appears as a clear area on a blue background.
RESULTS
Induced oxidative stress during HCV replication
Oxidative stress was measured in Huh-7 (control), Huh.8 (HCV subgenomic replicon) and Ava.1 (non-replicating HCV replicon) cells using flow cytometry (Figure 1 ). This method involves measuring H 2 O 2 production during the oxidative burst using the well known indicator DCFH-DA (2 ,7 -dichlorofluorescein diacetate; also known as 2 ,7 -dichlorodihydrofluorescin). DCF (2 ,7 -dichlorofluorescein) emission is measured at 525 + − 20 nm. H 2 O 2 and peroxides are able to oxidize the trapped dye DCFH to DCF, which is highly fluorescent at 530 nm. HCV-replicating Huh.8 cells produced 7-fold more reactive oxygen species (Figure 1 , peak C) when compared with Huh-7 cells (peak A). In contrast, HCV replication-defective Ava.1 cells, lacking the 47 amino acids of NS5A, produced comparable amounts of reactive oxygen species as control Huh-7 cells (Figure 1 , compare peaks A and B). Many basic events of cell regulation, such as protein phosphorylation and binding of transcription factors to consensus sites in DNA, are driven by physiological oxidants and antioxidant homoeostasis. In particular, key antioxidant SODs (Cu/Zn and Mn) are known to play a major role in counteracting oxidative stress. To understand the relationship between HCV infection and oxidative stress, extracts of HCV-replicating cells were assayed for Cu/Zn and MnSOD activity.
Induced MnSOD activity in HCV-replicating cells
Figure 2(A) shows the levels of SOD activity in Huh-7 (control), Huh.8 (HCV subgenomic replicon) and Ava.1 (non-replicating Figure 2C, lanes 2-4) . Ava.1 cell extracts showed an approx. 2-fold increase in MnSOD protein expression.
The human MnSOD promoter is activated in Huh.8 cells
To test whether transcriptional regulation is involved in the mechanism of increased MnSOD expression in HCV-replicating cells, DNA transfections were carried out using a 3400 bp human MnSOD promoter-luciferase reporter construct. Transfection of the MnSOD-LUC construct into Huh-7, Huh.8 and Ava.1 cells revealed that the 3400 bp promoter was activated in HCVreplicating cells (Figure 3 ). An approx. 4-fold increase in MnSOD promoter activity was seen in Huh.8 cells, consistent with increased MnSOD protein and enzyme activity. These results suggested that the MnSOD promoter is activated by HCV replication and protein expression. In the mutant Ava.1 cell line, partial activation (1.7-fold) of the MnSOD promoter was seen (Figure 3) . No change in luciferase expression was seen when a heterologous simian virus 40 (SV40)-LUC DNA was transfected into either Huh-7 or Huh.8 cells (results not shown). MAPK were activated in HCV-replicating cells, no changes in ERK1/2 activation were observed (results not shown).
NS5A mediates the induction of JNK and p38 MAPK in Huh-7 cells
We introduced the NS5A cDNA into a replication-defective adenovirus vector (Ad-NS5A) to permit rapid introduction into cells for further analysis of the signalling pathways. As a control, adenovirus encoding GFP (Ad-GFP) was constructed. Huh-7 cells were transduced with either Ad-GFP ( Figure 5, lane 3) or Ad-NS5A (lane 4). The expression of NS5A was confirmed by immunofluorescence (results not shown). Western blot analysis was performed using antibodies specific for phosphorylated MAPK and ERK. To serve as a positive control for induction of p38 MAPK and ERK, Huh-7 cells were osmotically shocked with a hypotonic buffer for 15 min ( Figure 5, lane 2) . Stress-activated signalling cascades play a crucial role during the cellular response to a wide variety of stress-inducing agents through the activation of AP-1 transcription factors [7] .
Induction of DNA binding of AP-1 in HCV subgenomic replicon-expressing cells
To test the hypothesis that NS5A contributes towards the accumulation of oxidative stress by activating the key stress-inducible transcription factor AP-1, we measured the DNA binding of AP-1 ( Figure 6 ). AP-1 is an important mediator of tumour promotion. Interactions between c-Jun and c-Fos proteins via leucine zipper domains have crucial regulatory implications for the expression of a wide variety of genes. As expected, AP-1 binding to DNA was increased several-fold in HCV-replicating cells ( Figure 6 , compare lanes 2-4 with lanes 5-7). Unlabelled competitor DNA (lanes 8 and 9) abrogated this interaction, thus establishing the specificity of the AP-1 complex.
Next, we determined whether activation of AP-1 in HCVreplicating cells could be prevented by the antioxidant NAC (N-acetylcysteine), which is known to repress stress-induced AP-1 activation [5] . Huh-7 and Huh.8 cells were exposed to 10 µM NAC for 12 h and nuclear extracts were tested for AP-1 binding ( Figure 6A ). We found that AP-1 binding to DNA was reduced in both control Huh-7 cells (lane 10) and HCV-replicating Huh.8 cells (lane 11), thus establishing the AP-1 specificity of the shifted band. Antibodies to c-Fos or c-Jun were able to supershift the AP-1 complex (lanes 12-15), but neither antibody shifted the AP-1 DNA probe (lane 16).
Activation of AP-1 by NS5A
The participation of c-Fos, c-Jun and JunB in AP-1 complex formation was tested by incubating nuclear extracts with specific blocking antibodies prior to adding the radiolabelled DNA. Nuclear extracts prepared from serum-starved Huh-7 cells were transduced at 25 plaque-forming units/cell with Ad-GFP or Ad-NS5A. Samples of 2, 10, 20, 40 and 60 µg of nuclear extract proteins from cells transduced with Ad-GFP ( Figure 6B , lanes 2-6) or Ad-NS5A (lanes 7-11) were used for AP-1 binding by band shift assay using a 32 P-labelled AP-1 consensus probe. Nuclear extracts from Ad-NS5A-transduced cells showed increased AP-1 binding when compared with equal amounts of nuclear extracts from Ad-GFP-transduced cells. PMA treatment followed by transduction with Ad-NS5A induced AP-1 binding further ( Figure 6B , compare lanes 12 and 13). When cells were exposed to the antioxidant DTT (10 µM) during Ad-NS5A transduction, significantly reduced AP-1 binding was seen ( Figure 6B, lane 14) , indicating the specificity of the AP-1 complex. To further confirm the authenticity of the AP-1 complex, an adenovirus encoding c-Fos expression was observed (lanes 1-3) . Ava.1 cells (lacking the 47 amino acids of NS5A) showed no change in c-Jun expression compared with controls.
Since only c-Jun expression was increased in HCV-replicating cells, we were interested to determine whether Ad-NS5A-transduced cells might also show an increase in c-Jun expression. Serum-starved Huh-7 cells were transduced with Ad-NS5A and lysates were prepared as described. As expected, enhanced expression of c-Jun was seen in Ad-NS5A-transduced Huh-7 cells ( Figure 7B, lane 2) . As a control, AP-1-depleted cell extracts were employed, and no c-Jun protein band was seen using antibodies to c-Jun (lane 3). Antibodies to c-Fos and c-Jun were used to deplete the extracts. As expected, extracts from PMA-treated cells showed an increase in c-Jun expression (lane 4). These results confirm that the increase in c-Jun expression in HCV-replicating cells is associated with functional NS5A expression.
Exogenous GST (glutathione S-transferase)-NS5A fails to induce AP-1 DNA-binding activity
To determine whether NS5A is physically required in the AP-1 complex for its activation, EMSA was performed with Huh-7 nuclear extracts in the presence of GST-NS5A. GST-NS5A (10, 20, 50 or 100 ng; Figure 8A , lanes 6-9) did not increase AP-1 binding. Since no induction of AP-1 binding by exogenous NS5A was observed, we believe that NS5A is not a component of the AP-1 complex. We propose that NS5A-induced signalling cascades within cells are required for AP-1 activation. To test this hypothesis, we measured the binding activity of the AP-1 responsive element [TRE; PMA ('TPA')-responsive element] within the cell using an AP-1-LUC reporter construct. pAP-1-LUC was transfected into Huh-7 and HCV-replicating Huh.8 cells and luciferase activity was measured ( Figure 8B ). An approx. 5-fold increase in luciferase activity was observed in HCV repliconcontaining cells, suggesting that NS5A-mediated activation of JNK and p38 MAPK is essential to activate AP-1. No difference in luciferase expression was seen when heterologous SV40-LUC DNA was transfected into Huh-7 or Huh.8 cells (results not shown). 
Inhibitors of p38 MAPK and JNK block MnSOD activation in HCV-replicating cells
Finally, we investigated possible roles of p38 MAPK, ERK1/2 and JNK in the process of MnSOD activation. Huh.8 cells were exposed to the a p38 MAPK inhibitor (SB203580), a JNK blocker (JNKI1) or an ERK1/2 inhibitor (U0126) for 12 h. Cell extracts were assayed for MnSOD protein expression using anti-MnSOD antibodies ( Figure 9A ). The p38 MAPK antagonist SB203580 (lane 4) and the JNK blocker JNKI1 (lane 5) blocked MnSOD activation, whereas the ERK1/2 inhibitor U0126 had no effect (lane 3). The observed inhibition is likely to be mediated by the activity of NS5A via activation of AP-1. To confirm this, Huh-7 cells were transduced with either Ad-NS5A ( Figure 9B , upper Figure 9B, lanes 1-4) . As expected Ad-NS5A-transduced cells showed activated MnSOD expression when compared with Ad-GFP-transduced cells ( Figure 9B , compare lanes 1 in upper and lower panels). p38 MAPK and JNK inhibitors reduced the basal expression and activation of MnSOD, whereas the ERK inhibitor had no effect.
DISCUSSION
The results presented here suggest a cascade of signalling events that are triggered by HCV-induced oxidative stress (Figure 10 ). The HCV protein NS5A seems to play a critical role in the activation of p38 MAPK, JNK and AP-1, leading to increased MnSOD antioxidant responses. The activation of AP-1 and MnSOD by HCV NS5A may be instrumental in the regulation of host oxidant status, and underscores the potential importance of this protein.
The observed cellular responses are designed to counteract the oxidative stress induced by HCV protein expression. The first enzymes in the detoxification of oxygen free radicals are the SODs (MnSOD and Cu/ZnSOD). SODs catalyse the dismutation of superoxide radicals into hydrogen peroxide and molecular oxygen [35] [36] [37] . NFκB, TNFα (tumour necrosis factor α), interleukin 6, the p38 MAPK signalling cascade and the transcription factors AP-1 and AP-2 contribute to the regulation of MnSOD; however, the exact roles of these cellular transcription factors have not been completely defined [35] [36] [37] 41, [44] [45] [46] [47] [48] . AP-1 contributes to the control of MnSOD and is activated in response to environmental stress, radiation and growth factors, and is a positive regulator of human and Drosophila melanogaster MnSODs [41, [45] [46] [47] [48] . Exposure to superoxides and secondary oxidants leads to induction of c-Fos, c-Jun, [29, 36] and c-Myc [49] , increased cellular proliferation [50] , and lung hyperplasia and fibrosis in hamsters [36] . Induction of the MnSOD gene by arachidonic acid is mediated by reactive oxygen species and the p38 MAPK signalling pathway in human HepG2 hepatoma cells [37] . The AP-1 activation response was blocked by the known AP-1 inhibitors NAC and DTT [5] , thus establishing AP-1 specificity in both control and HCV-replicating cells ( Figure 6 ). Consistent with this observation, a decrease in MnSOD expression following treatment with p38 MAPK and JNK inhibitors was seen in both HCV-replicating cells and Ad-NS5A-transduced cells ( Figure 9) . Interestingly, the antioxidants NAC and DTT also blocked the replication of HCV in Huh.8 cells, by 75 % and 50 % respectively (results not shown). How these antioxidants may contribute to a decrease in HCV replication remains to be investigated. The basal expression of MnSOD was also blocked in Ad-GFP-transduced Huh-7 cells by p38 MAPK and JNK inhibitors, suggesting the putative involvement of p38 MAPK and JNK in MnSOD regulation. There are no previous results indicating the involvement of JNK in MnSOD regulation, and therefore the present study identifies an additional signalling pathway for antioxidant regulation.
HCV NS5A is a serine phosphoprotein consisting of two isoforms, p56 and p58 [51] , which binds to multitude of cellular proteins, including PKR, phosphoinositide 3-kinase, SRCAP, Grb2, TBP and p53 [16] [17] [18] [19] [20] [21] [22] [23] . The induction of oxidative stress and the activation of MnSOD by NS5A alone or within the HCV subgenomic replicon via the stress-activated p38 MAPK and JNK pathways may be linked with p53. Diminished p53 function within cells expressing HCV NS5A [22, 23] may induce a cascade of events leading to increased stress, as p53 has been linked to oxidative stress and MnSOD expression via JNK, p38 MAPK and ERK1/2 [25, 33, 34, 38, 53, 54] .
Since exogenously added NS5A protein was unable to induce AP-1 binding to DNA, we argue that NS5A is not a component of the AP-1 complex. While NS5A expression induced an approx. 3-fold increase in c-Jun protein levels, it remains to be seen to what extent NS5A exerts its influence on the composition of c-Jun and c-Fos homo-and hetero-dimers. Our results are consistent with the observation of AP-1 activation by other viruses [44] . Hepatitis B virus HBx protein has been shown to induce AP-1 by activation of ERK and JNK [52] , while HIV Tat activates AP-1 through an oxidant-dependent mechanism involving serum response elements and ternary complex factors [30] . It remains to be seen whether NS5A-mediated AP-1 activation also involves these components.
Different viruses have variable responses with regard to superoxide. HIV-1 infection induces the up-regulation of MnSOD transcription in CD4 + lymphocytes and overexpression in purified normal human monocyte-derived macrophages [53] . The up-regulation of MnSOD is concomitant with TNFα and interleukin-6 production. HIV Tat protein represses MnSOD expression in HeLa cells [41] . Rhinovirus infection of respiratory epithelial cells led to an increase in Cu/ZnSOD levels, but not to a change in MnSOD expression [54] .
Our observations are novel and provide important clues to the oxidant and antioxidant status of HCV-infected cells that may be relevant for new therapeutic treatments. A role for p38 MAPK in MnSOD expression is consistent with the results of Bianchi et al. [37] . In addition to NS5A, C protein of HCV also activates ERK, JNK and p38 MAPK [32] . The sustained activation of MnSOD may be an acute adaptive response to oxidative stress, and damage may occur when the oxidant burden overwhelms the cell's capacity to detoxify at the late chronic stage of HCV infection. This activation may protect HCV-replicating cells from cell death, as MnSOD and JNK activities mediated by reactive oxygen species are reported to represent a protective mechanism against cell death [53, 55, 56] . The antioxidant MnSOD responses may collapse after a prolonged battle with the oxidant burden imposed by cytokines and other secondary effects associated with HCV infection. It will be interesting to determine which cytokine and stress-signalling pathways play a role at various stages of HCV infection. This may provide important clues to the mechanisms involved in the development of chronic liver disease with the potential of hepatocellular carcinoma.
